These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36510993)

  • 1. Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer.
    Mehraj A; Baba AA; Khan B; Khan MA; Wani RA; Parray FQ; Chowdri NA
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S391-S396. PubMed ID: 36510993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
    Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
    World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Eraslan E; Adas YG; Yildiz F; Gulesen AI; Karacin C; Arslan UY
    J Coll Physicians Surg Pak; 2021 Apr; 31(4):399-404. PubMed ID: 33866724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study.
    Knight KA; Drami I; McMillan DC; Horgan PG; Park JH; Jenkins JT; Roxburgh CSD
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3409-3420. PubMed ID: 33710416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
    Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
    Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
    West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
    Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
    Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
    Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.
    Yoon HI; Koom WS; Kim YB; Min BS; Lee KY; Kim NK; Shin SJ; Ahn JB; Keum KC
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):399-409. PubMed ID: 24390211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 13. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
    Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
    Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre cohort study assessing the utility of routine blood tests as adjuncts to identify complete responders in rectal cancer following neoadjuvant chemoradiotherapy.
    Eastern Rectal Cancer Response Collaborative, Ireland
    Int J Colorectal Dis; 2022 Apr; 37(4):957-965. PubMed ID: 35325271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Utilization and Outcomes for Locally Advanced Rectal Cancer in Older Patients.
    Nassoiy S; Christopher W; Marcus R; Keller J; Weiss J; Chang SC; Foshag L; Essner R; Fischer T; Goldfarb M
    JAMA Surg; 2022 Nov; 157(11):e224456. PubMed ID: 36169964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Krauthamer M; Rouvinov K; Ariad S; Man S; Walfish S; Pinsk I; Sztarker I; Charkovsky T; Lavrenkov K
    Oncology; 2013; 85(1):27-32. PubMed ID: 23816828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer.
    Peng J; Lin J; Qiu M; Wu X; Lu Z; Chen G; Li L; Ding P; Gao Y; Zeng Z; Zhang H; Wan D; Pan Z
    Clinics (Sao Paulo); 2016 Aug; 71(8):449-54. PubMed ID: 27626475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-Term Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer].
    Sakamoto Y; Kurebayashi H; Sakamoto S; Matsunaka T; Maegawa N; Shimada M; Tagai N; Sawai K; Morikawa M; Koneri K; Tamaki M; Murakami M; Hirono Y; Goi T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1762-1764. PubMed ID: 38303199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Sakin A; Sahin S; Karyagar SS; Karyagar S; Atci M; Akboru MH; Cihan S
    J Gastrointest Cancer; 2022 Jun; 53(2):341-347. PubMed ID: 33651265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    West MA; Astin R; Moyses HE; Cave J; White D; Levett DZH; Bates A; Brown G; Grocott MPW; Jack S
    Acta Oncol; 2019 May; 58(5):588-595. PubMed ID: 30724668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.